Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)Read more
Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD
The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)Read more
ImaBiotech, has received an impressive number of awards since being founded by Jonathan Stauber. These honors demonstrate ImaBiotech’s ongoing commitment to continuously grow and develop the science and the company.
Here is the list of ImaBiotech’s prizes and certificates received between 2008 and 2017:
In 2017, ImaBiotech was laureate of the "Champion de la Croissance 2017" recognition by Les Echos and Statista.
On August 29, 2014 in Berlin, Germany at the 12th European Congress of Toxicologic Pathology, The French Society of Toxicologic Pathology awarded "Best Poster" Gregory Hamm for the poster : Assessment of drug toxicity in small histological structure of the eye: Application of Mass Spectrometry Imaging in Ophtalmic context
Eurasanté’s prize for “Innovation and development” on April 11, 2014 awarded by the Société Industrielle du Nord de France.
ImaBiotech was named laureate of the Bpifrance recognition since 2014. This annual certification rewards the best companies of the region for their growth potential.
In 2010, ImaBiotech won the LMI Innovation award. This honor was awarded by the CCI Grand Lille and rewards a company based on the structure and innovation of a project.
On June 30, 2010 our CEO Jonathan Stauber has been named laureate of “The creation and development” prize given by the Ministry of Education and Research.
In 2008, Jonathan Stauber was laureate of the 10th national competition of tech companies’ creation in the “emergence” category issued by the Ministry of Education and Research.
In 2009, ImaBiotech was named laureate of the CGPME and ISEG recognition.